Antibody and antigen binding fragments thereof
US-2024385186-A1 · Nov 21, 2024 · US
US9107905B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9107905-B2 |
| Application number | US-201313747413-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 22, 2013 |
| Priority date | Aug 25, 2006 |
| Publication date | Aug 18, 2015 |
| Grant date | Aug 18, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to modulation of fungal morphology between yeast-to-hyphal growth transition by controlling muramyl-L-alanine concentration and uses thereof.
Opening claim text (preview).
The invention claimed is: 1. A method of determining the extent of Candida hyphal growth in a body fluid sample obtained from a patient having a Candida infection, comprising the step of measuring the amount of muramyl-L-alanine and/or compounds that include muramyl-L-alanine in their core structure in the body fluid sample. 2. The method of claim 1 , further comprising the step of determining a treatment for the patient according to whether hyphal growth i…
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Physics · mapped topic
Chemistry & Metallurgy · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.